Solace Pharmaceuticals Inc. Lands $6,749,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0a546084-dd3e-4742-ae5f-5b4928fd7810&Preview=1 -
Date
3/31/2008 -
Company Name
Solace Pharmaceuticals Inc. -
Mailing Address
222 Berkeley Street Boston, MA 02116 -
Company Description
Solace was co-founded in March 2006 by PureTech Ventures and a preeminent team of scientific, clinical, regulatory and drug development experts who are collaborating to translate groundbreaking scientific discoveries in pain biology into innovative, effective therapeutic strategies for addressing chronic pain. Solace Pharmaceuticals is developing innovative therapies for treating chronic pain based on recent groundbreaking scientific discoveries. The company has promising programs at varying stages of preclinical and clinical development in its pipeline. -
Website
http://www.solacepharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$6,749,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
InterWest Partners -
Venture Investor
Polaris Venture Partners
